(Q67748205)

English

Urinary excretion of throm☐ane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary throm☐ane B2 and 6-keto-prostaglandin F1α in healthy subjects

scientific article published on 01 February 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1737057%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1737057%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Urinary excretion of throm☐ane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary throm☐ane B2 and 6-keto-prostaglandin F1α in healthy subjects (English)

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

1 reference

based on heuristic

inferred from title

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

author name string

C. Chiabrando

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1737057

12 November 2022

L. Rivoltella

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1737057

12 November 2022

L. Martelli

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1737057

12 November 2022

S. Valzacchi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1737057

12 November 2022

R. Fanelli

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1737057

12 November 2022

language of work or name

0 references

publication date

1 February 1992

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1737057%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

3 February 1992

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1737057

12 November 2022

full work available at URL

https://api.elsevier.com/content/article/PII:016748899290044C?httpAccept=text/xml

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

https://api.elsevier.com/content/article/PII:016748899290044C?httpAccept=text/plain

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Biochimica et Biophysica Acta

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1737057%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1133

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1737057%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1737057%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

247-254

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1737057%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease

1

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Measurement of renal and non-renal eicosanoid synthesis

2

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Regulation of urinary thromboxane B2 in man: influence of urinary flow rate and tubular transport

4

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Excretion of primary prostanoids and their metabolites during acute volume expansion

5

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

American Journal of Physiology

6

242

E171

author name string

Zipser

publication date

1982

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Clinical implications of prostaglandin and thromboxane A2 formation (1).

8

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Clinical implications of prostaglandin and thromboxane A2 formation (2).

9

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

The clinical significance of inhibition of renal prostaglandin synthesis

10

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and back

12

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects

13

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects

14

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man

15

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase

16

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Paired analysis of urinary thromboxane B2 metabolites in humans.

17

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Effects of low-dose aspirin on endogenous eicosanoid formation in normal and atherosclerotic men

18

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Cumulative inhibitory effect of low-dose aspirin on vascular prostacyclin and platelet thromboxane production in patients with atherosclerosis

19

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

In vivo measurement of thromboxane B2 and 6-keto-prostaglandin F1 alpha in humans in response to a standardized vascular injury and the influence of aspirin

20

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo

21

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Antibody-mediated extraction/negative-ion chemical ionization mass spectrometric measurement of thromboxane B 2 and 2,3-dinor-thromboxane B 2 in human and rat urine

22

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry

23

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Urinary prostaglandins. Identification and origin

24

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Evidence for an extra-renal origin of urinary prostaglandin E2 in healthy men

25

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Rapid and slow hydroxylators of seminal E prostaglandins

26

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus

27

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase

28

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine

29

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Effect of Low-Dose Aspirin on Fetal and Maternal Generation of Thromboxane by Platelets in Women at Risk for Ppregnancy-Induced Hypertension

30

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Smoking alters thromboxane metabolism in man.

34

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets

38

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Differential inhibition of thromboxane A2 and prostacyclin synthesis by low dose acetylsalicylic acid in atherosclerotic patients

39

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Urinary excretion of 2,3-dinor-thromboxane B2 in man under normal conditions, following drugs and during some pathological conditions

40

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

American Journal of Physiology

41

255

H15

author name string

Wennmalm

publication date

1988

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Biochemical selectivity of oral versus intravenous aspirin in rats. Inhibition by oral aspirin of cyclooxygenase activity in platelets and presystemic but not systemic vessels

42

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells

44

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Primary prevention of vascular disease by aspirin

45

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Aspirin in cardiovascular disease

46

1 reference

10.1016/0167-4889(92)90044-C

https://api.crossref.org/works/10.1016/0167-4889(92)90044-C

12 November 2022

Identifiers

10.1016/0167-4889(92)90044-C

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1737057%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1737057%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67748205&oldid=1814576559"